Close Menu

There's promise and excitement surrounding genetic and genomic tests, but the New York Times reports there's also the potential for fraud as such testing has transformed into a $6 billion industry.

"It sounds so legitimate — who doesn't want safe medicine?" Howard McLeod, the medical director of the personalized medicine institute for Moffitt Cancer Center, tells the Times.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.